Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,200 signal articles · 243 in last 24h · 120,199 total before filter · latest 28m ago
243last 24h
1428last 7d
241● bullish (7d)
156● bearish (7d)
205publishers
AllMacro256Earnings539M&A101Regulatory19Product10Analyst21
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Tencent (SEHK:700) Backs Manus Buyback And Enflame IPO In China AI Push
Simply Wall St.62d agobullish
Tencent (SEHK:700) Backs Manus Buyback And Enflame IPO In China AI Push

Tencent Holdings (SEHK:700) is part of the buyer group for AI startup Manus after regulators required Meta to unwind its acquisition. Tencent is a major shareholder and customer of Shanghai Enflame Technology, an AI chip supplier preparing for a public listing. Both developments highlight Tencent's involvement in AI software and hardware across China and global markets. Tencent Holdings sits at the center of China's internet and gaming industries and is increasingly active across artificial...

AMD (AMD) Buys MEXT To Tackle AI Data Center Memory Bottlenecks
Simply Wall St.62d agobullish
AMD (AMD) Buys MEXT To Tackle AI Data Center Memory Bottlenecks

Advanced Micro Devices (NasdaqGS:AMD) has agreed to acquire MEXT, an AI native memory optimization company focused on data center workloads. The deal targets memory bottlenecks in enterprise and cloud AI environments, with MEXT's technology expected to be integrated into AMD's data center portfolio. The acquisition supports AMD's push to build a more complete AI infrastructure stack across both hardware and software layers. Advanced Micro Devices enters this deal with strong recent stock...

SpaceX (SPCX) Buys Cursor For $60 Billion As Wall Street Piles In
Simply Wall St.62d agobullish
SpaceX (SPCX) Buys Cursor For $60 Billion As Wall Street Piles In

SpaceX, now trading as NasdaqGS:SPCX, has agreed to acquire enterprise AI company Cursor in an all stock deal valued at US$60b. The transaction follows the world’s largest ever IPO for SPCX and comes alongside a surge in ETF launches and early index inclusions tied to the stock. Options trading volumes in SPCX have reached record levels within days of listing, drawing attention from both institutional and retail investors. Space Exploration Technologies, better known as SpaceX, is expanding...

Intel shares rise after Trump announces Apple partnership
Reuters Videos62d agobullishVIDEO
Intel shares rise after Trump announces Apple partnership

<body><p>STORY: ::Intel</p><p>::Archive</p><p>Shares of Intel rose as much as nearly 12% on Thursday, after U.S. President Donald Trump said the company would partner with Apple on chip design and production...</p><p>:: Intel</p><p>in what would be a major boost for Intel's efforts to turn around its business.&nbsp;</p><p>A contract with Apple would lock in steady demand from the iPhone maker, boosting Intel's reputation and sales as it looks to close the gap with rival TSMC, the world's biggest contract chipmaker.</p><p>::Archive</p><p>::AMD</p><p>For Apple, the deal would help diversify its manufacturing base and add chip capacity at a time when TSMC, its key partner, has been stretched thin by surging demand from AI chip-making clients such as Nvidia and AMD.</p><p>Trump's social media post about the agreement did not specify which chips Intel would make for Apple.</p><p>The president said it was his latest effort to help Intel, in which the U.S. government has a 10% stake.</p><p>::Archive</p><p>The Trump administration has been stepping up efforts to secure U.S. supply chains for semiconductors and critical minerals, including taking equity stakes in companies to reduce reliance on China.</p><p>Apple and Intel did not immediately respond to Reuters requests for comment.</p></body>

Investing.com62d agobullish
Kardigan shares soar after Nasdaq debut

Investing.com -- Kardigan Inc. shares rose iver 27% roughly one hour into its Nasdaq debut on Thursday, after the heart-health focused biotech raised $400 million in an initial public offering.